Korea Union Pharmaceutical Acquires Convertible Bonds Worth 26.5 Billion KRW Before Maturity
Korea Union Pharmaceutical announced on the 4th that it will acquire the first series of anonymous, unsubordinated private convertible bonds with detachable warrants, worth approximately 26.5 billion KRW, before maturity. The conversion price per share is 11,124 KRW. The reason for the acquisition is the bondholders' exercise of the early redemption right (Put Option).
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Sold Everything Fearing Bankruptcy, Then It Soared 3,900 Times: How a Stock Once Feared for Delisting Became an AI Powerhouse"
- Court Partially Grants Samsung Electronics' Injunction to Prohibit Industrial Action... 100 Million Won Penalty Per Day for Violations
- Strike Risk Looms Over Pangyo... Kakao Enters Labor Commission Mediation Today
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
